InsidersTradesSigma
Follow the 南模生物 share price and the full management transaction log of the company, a listed issuer based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). The latest transaction was reported on 15 July 2026 (Sale). Among the most active insiders: 王津津. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Nanmo Biology是一家在上海证券交易所上市的公司，专注于生物制药领域。该公司致力于疾病治疗创新解决方案的研发。